Develops RNA-targeted small molecule medicines using proprietary technology to create innovative oral treatments for genetic diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Arrakis Therapeutics develops RNA-targeted small molecule (rSM) medicines using a proprietary technology platform to unlock new biology and create oral medicines for patients. The company’s pipeline includes both proprietary and partnered programs focused on pioneering this new class of genetic medicines.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Arrakis Therapeutics Management Team
Investors
Advent Life Sciences
Canaan Partners
Celgene Corporation
Henri Termeer
Osage University Partners
Pfizer Strategic Investments Group (PSIG)
Arrakis Therapeutics Valuations & Financials
View real-time NPM data on Arrakis Therapeutics stock including daily Arrakis Therapeutics stock price estimates, valuation history, and historical share price information. Access Arrakis Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Arrakis Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Arrakis Therapeutics? Get in touch to learn more.
Similar Companies
like Arrakis Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
TinyFish
AI & Machine Learning
Innovator that automates high-value workflows using adaptive agents for seamless, scaled web interaction.
Blueprint Title
Commerce & Marketplaces
Provides digital marketing and technology solutions to optimize brand strategy, engagement, and campaign performance.
Collaborative Drug Discovery
Healthcare & Life Sciences
Facilitates secure management and collaboration of scientific data for drug discovery, enhancing productivity and protecting intellectual property.
DubClub
Media & Entertainment
Helps sports betting experts monetize their picks and insights by connecting them with subscribers seeking betting advice and community.
Atheer
AI & Machine Learning
Enabling technicians who follow field service workflows to access AR-guided instructions and collaborate remotely for faster, compliant execution.
N-Drip
Climate & Sustainability
Develops gravity-powered micro-irrigation systems that convert flood irrigation into precise watering solutions, saving water and energy.
Garage
Commerce & Marketplaces
Connects agencies to surplus emergency vehicles and gear via a unified marketplace with logistics and assurance services.
Jifiti
FinTech
Enables embedded lending and flexible point‑of‑sale financing solutions for banks, lenders, and merchants.
FAQ
We have answers
Arrakis Therapeutics stock does not trade on public stock exchanges. Arrakis Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Arrakis Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Arrakis Therapeutics Stock does not trade on public stock exchanges. In order to sell Arrakis Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Arrakis Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Arrakis Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Arrakis Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Arrakis Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Arrakis Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Arrakis Therapeutics is a private company and has not had an IPO. There is currently no Arrakis Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Arrakis Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
